Ballard Heather A, Leavitt Olga S, Chin Anthony C, Kabre Rashmi, Weese-Mayer Debra E, Hajduk John, Jagannathan Narasimhan
Department of Pediatric Anesthesiology, Feinberg School of Medicine, Northwestern University, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Department of Pediatric Surgery, Feinberg School of Medicine, Northwestern University, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Paediatr Anaesth. 2018 Nov;28(11):963-973. doi: 10.1111/pan.13475. Epub 2018 Sep 24.
Congenital Central Hypoventilation Syndrome and Rapid-Onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation are rare neurocristopathies characterized by autonomic dysregulation including bradyarrhythmias, abnormal temperature control, and most significantly, abnormal control of breathing leading to tracheostomy and ventilator dependence as life support. Surgical advancements have made phrenic nerve-diaphragm pacemakers available, to eliminate the tether to a mechanical ventilator for 12-15 hours each day. The thoracoscopic approach to implantation has allowed for a less invasive approach which may have implications for pain control and recovery time. However, thoracoscopic implantation of these devices presents several challenges to the anesthesiologist in these complex ventilator-dependent patients, including, but not limited to, sequential lung isolation, prevention of hypothermia, and management of arrhythmias. Postoperative challenges may also include strategies to treat hemodynamic instability, managing the ventilator following lung derecruitment, and providing adequate pain control.
We aimed to describe the anesthetic management of Congenital Central Hypoventilation Syndrome and Rapid-Onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation patients undergoing thoracoscopic phrenic nerve-diaphragm pacemaker implantation and the nature and incidence of perioperative complications.
A retrospective chart review was performed of 14 children with Congenital Central Hypoventilation Syndrome and Rapid-Onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation undergoing phrenic nerve-diaphragm pacemaker implantation at a single academic pediatric hospital between 2009 and 2017. Demographic information, intraoperative management, and perioperative complications were analyzed from patient records.
Twelve of 14 patients (86%) underwent an inhalational induction via tracheostomy. Lung isolation was achieved via fiberoptic guidance of a single lumen endotracheal tube sequentially into the right or left mainstem bronchi for 12 patients (86%). Double lumen endotracheal tubes were utilized in two patients (7%) and bronchial blockers in two patients (7%) for lung isolation. Anesthesia was maintained using a balanced technique of volatile agents (sevoflurane/isoflurane) and opioids (fentanyl). Bradyarrhythmias developed in six patients (43%) during surgery, 5 (36%) responded to anticholinergics and one patient (7%) required backup cardiac pacing using a previously implanted bipolar cardiac pacemaker. Intraoperative hypothermia (<35.5°C) was present in five patients (36%) despite the use of warming devices. Hypercarbia (>50 mm Hg) during lung isolation was present in eight patients (57%) and hemoglobin desaturation (<90%) in four patients (29%). Postoperatively, oxygen desaturation was a common complication with nine patients (64%) requiring supplemental oxygen administration via mechanical ventilator or manual bag ventilation. Opioids via patient-controlled analgesia devices (12 patients, 86%) or intermittent injection (two patients, 14%) were administered to all patients for postoperative pain control. Phrenic nerve-diaphragm pacemaker placement was successful thoracoscopically in all patients with no perioperative mortality.
The main anesthetic challenges in patients with Congenital Central Hypoventilation Syndrome and Rapid-Onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation include hemodynamic instability, the propensity to develop hypothermia, hypercarbia/hypoxemia, and the need to perform bilateral sequential lung isolation requisite to the thoracoscopic implantation technique. Most anesthetic agents can be used safely in these patients; however, adequate knowledge of the susceptibility to complications, coupled with adequate preparation and understanding of the innate disease characteristics, are necessary to treat anticipated complications.
先天性中枢性低通气综合征以及伴有下丘脑功能障碍、低通气和自主神经失调的快速进展性肥胖症是罕见的神经嵴病变,其特征为自主神经失调,包括缓慢性心律失常、体温控制异常,最显著的是呼吸控制异常,导致气管切开和依赖呼吸机维持生命。外科技术的进步使得膈神经 - 膈肌起搏器得以应用,从而使患者每天可摆脱机械通气束缚12至15小时。胸腔镜植入方法具有创伤较小的特点,这可能对疼痛控制和恢复时间产生影响。然而,在这些复杂的依赖呼吸机的患者中,胸腔镜植入这些设备给麻醉医生带来了诸多挑战,包括但不限于序贯性肺隔离、预防体温过低以及心律失常的处理。术后挑战还可能包括治疗血流动力学不稳定的策略、肺复张后呼吸机的管理以及提供充分的疼痛控制。
我们旨在描述先天性中枢性低通气综合征以及伴有下丘脑功能障碍、低通气和自主神经失调的快速进展性肥胖症患者接受胸腔镜膈神经 - 膈肌起搏器植入时的麻醉管理以及围手术期并发症的性质和发生率。
对2009年至2017年间在一家学术性儿科医院接受膈神经 - 膈肌起搏器植入的14例先天性中枢性低通气综合征以及伴有下丘脑功能障碍、低通气和自主神经失调的快速进展性肥胖症患儿进行回顾性病历审查。从患者记录中分析人口统计学信息、术中管理和围手术期并发症。
14例患者中有12例(占86%)通过气管切开进行吸入诱导。12例患者(占86%)通过单腔气管导管在纤维支气管镜引导下依次进入右或左主支气管实现肺隔离。2例患者(占7%)使用双腔气管导管,2例患者(占7%)使用支气管封堵器进行肺隔离。麻醉维持采用挥发性麻醉剂(七氟醚/异氟醚)和阿片类药物(芬太尼)的平衡技术。6例患者(占43%)在手术期间发生缓慢性心律失常,5例(占36%)对抗胆碱能药物有反应,1例患者(占7%)需要使用先前植入的双极心脏起搏器进行备用心脏起搏。尽管使用了保暖设备,仍有5例患者(占36%)术中体温过低(<35.5°C)。肺隔离期间8例患者(占57%)出现高碳酸血症(>50 mmHg),4例患者(占29%)出现血红蛋白饱和度降低(<90%)。术后,氧饱和度降低是常见并发症,9例患者(占64%)需要通过机械通气或手动球囊通气给予补充氧气。所有患者均通过患者自控镇痛设备(12例患者,占86%)或间歇性注射(2例患者,占14%)给予阿片类药物进行术后疼痛控制。所有患者胸腔镜下膈神经 - 膈肌起搏器放置均成功,无围手术期死亡。
先天性中枢性低通气综合征以及伴有下丘脑功能障碍、低通气和自主神经失调的快速进展性肥胖症患者的主要麻醉挑战包括血流动力学不稳定、体温过低、高碳酸血症/低氧血症的倾向以及胸腔镜植入技术所需的双侧序贯性肺隔离。大多数麻醉药物可安全用于这些患者;然而,充分了解并发症的易感性,以及充分的准备和对先天性疾病特征的理解,对于治疗预期并发症是必要的。